Lilly Centre for Clinical Pharmacology (LCCP) is Eli Lilly and Company’s only internal Phase 1 research unit, with a specialist team of scientists, doctors, nurses, and pharmacists dedicated to designing and conducting early-phase human trials of Lilly’s medicines for the future. At the heart of LCCP is a world-class Clinical Research Unit, where healthy subjects and patients participate in clinical trials. We perform studies in Lilly’s areas of interest, including Diabetes, Neuroscience, Oncology, and Autoimmune Disease. The studies conducted here help bring new medicines to people around the world.